Global Levonorgestrel API Market Growth 2023-2030
- Category: Healthcare
- Published Date: May 2023
- Publisher: LP Information
- Pages: 93
As the global economy mends, the 2022 growth of Levonorgestrel API will have significant change from previous year. According to our (Intelligence Market Report) latest study, the global Levonorgestrel API market size is USD million in 2022 from USD 47 million in 2022, with a change of % between 2022 and 2022. The global Levonorgestrel API market size will reach USD 62 million in 2030, growing at a CAGR of 4.1% over the analysis period.
The United States Levonorgestrel API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during review period. China constitutes a % market for the global Levonorgestrel API market, reaching US$ million by the year 2030. As for the Europe Levonorgestrel API landscape, Germany is projected to reach US$ million by 2030 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Levonorgestrel API players cover Bayer HealthCare, Qinhuangdao Zizhu Pharmaceutical, Yangzhou Pharmaceutical, and Lupin, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Levonorgestrel API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2019-2022, in Section 2.3; and forecast to 2030 in section 12.6
Short-Acting Contraceptive API
Long-Acting Contraceptive API
Segmentation by application: breakdown data from 2019-2022, in Section 2.4; and forecast to 2030 in section 12.7.
Levonorgestrel Tablet
Mixture Products
Hormone-releasing IUD
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer HealthCare
Qinhuangdao Zizhu Pharmaceutical
Yangzhou Pharmaceutical
Lupin
Hubei Gedian Humanwell
Sterling Spa
Formos
Huazhong Pharm
ASG Biochem
The United States Levonorgestrel API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during review period. China constitutes a % market for the global Levonorgestrel API market, reaching US$ million by the year 2030. As for the Europe Levonorgestrel API landscape, Germany is projected to reach US$ million by 2030 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Levonorgestrel API players cover Bayer HealthCare, Qinhuangdao Zizhu Pharmaceutical, Yangzhou Pharmaceutical, and Lupin, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Levonorgestrel API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2019-2022, in Section 2.3; and forecast to 2030 in section 12.6
Short-Acting Contraceptive API
Long-Acting Contraceptive API
Segmentation by application: breakdown data from 2019-2022, in Section 2.4; and forecast to 2030 in section 12.7.
Levonorgestrel Tablet
Mixture Products
Hormone-releasing IUD
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer HealthCare
Qinhuangdao Zizhu Pharmaceutical
Yangzhou Pharmaceutical
Lupin
Hubei Gedian Humanwell
Sterling Spa
Formos
Huazhong Pharm
ASG Biochem
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Levonorgestrel API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Levonorgestrel API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Levonorgestrel API by Country/Region, 2019, 2023 & 2030
2.2 Levonorgestrel API Segment by Type
2.2.1 Short-Acting Contraceptive API
2.2.2 Long-Acting Contraceptive API
2.3 Levonorgestrel API Sales by Type
2.3.1 Global Levonorgestrel API Sales Market Share by Type (2019-2022)
2.3.2 Global Levonorgestrel API Revenue and Market Share by Type (2019-2022)
2.3.3 Global Levonorgestrel API Sale Price by Type (2019-2022)
2.4 Levonorgestrel API Segment by Application
2.4.1 Levonorgestrel Tablet
2.4.2 Mixture Products
2.4.3 Hormone-releasing IUD
2.5 Levonorgestrel API Sales by Application
2.5.1 Global Levonorgestrel API Sale Market Share by Application (2019-2022)
2.5.2 Global Levonorgestrel API Revenue and Market Share by Application (2019-2022)
2.5.3 Global Levonorgestrel API Sale Price by Application (2019-2022)
3 Global Levonorgestrel API by Company
3.1 Global Levonorgestrel API Breakdown Data by Company
3.1.1 Global Levonorgestrel API Annual Sales by Company (2020-2022)
3.1.2 Global Levonorgestrel API Sales Market Share by Company (2020-2022)
3.2 Global Levonorgestrel API Annual Revenue by Company (2020-2022)
3.2.1 Global Levonorgestrel API Revenue by Company (2020-2022)
3.2.2 Global Levonorgestrel API Revenue Market Share by Company (2020-2022)
3.3 Global Levonorgestrel API Sale Price by Company
3.4 Key Manufacturers Levonorgestrel API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Levonorgestrel API Product Location Distribution
3.4.2 Players Levonorgestrel API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Levonorgestrel API by Geographic Region
4.1 World Historic Levonorgestrel API Market Size by Geographic Region (2019-2022)
4.1.1 Global Levonorgestrel API Annual Sales by Geographic Region (2019-2022)
4.1.2 Global Levonorgestrel API Annual Revenue by Geographic Region
4.2 World Historic Levonorgestrel API Market Size by Country/Region (2019-2022)
4.2.1 Global Levonorgestrel API Annual Sales by Country/Region (2019-2022)
4.2.2 Global Levonorgestrel API Annual Revenue by Country/Region
4.3 Americas Levonorgestrel API Sales Growth
4.4 APAC Levonorgestrel API Sales Growth
4.5 Europe Levonorgestrel API Sales Growth
4.6 Middle East & Africa Levonorgestrel API Sales Growth
5 Americas
5.1 Americas Levonorgestrel API Sales by Country
5.1.1 Americas Levonorgestrel API Sales by Country (2019-2022)
5.1.2 Americas Levonorgestrel API Revenue by Country (2019-2022)
5.2 Americas Levonorgestrel API Sales by Type
5.3 Americas Levonorgestrel API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Levonorgestrel API Sales by Region
6.1.1 APAC Levonorgestrel API Sales by Region (2019-2022)
6.1.2 APAC Levonorgestrel API Revenue by Region (2019-2022)
6.2 APAC Levonorgestrel API Sales by Type
6.3 APAC Levonorgestrel API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Levonorgestrel API by Country
7.1.1 Europe Levonorgestrel API Sales by Country (2019-2022)
7.1.2 Europe Levonorgestrel API Revenue by Country (2019-2022)
7.2 Europe Levonorgestrel API Sales by Type
7.3 Europe Levonorgestrel API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Levonorgestrel API by Country
8.1.1 Middle East & Africa Levonorgestrel API Sales by Country (2019-2022)
8.1.2 Middle East & Africa Levonorgestrel API Revenue by Country (2019-2022)
8.2 Middle East & Africa Levonorgestrel API Sales by Type
8.3 Middle East & Africa Levonorgestrel API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Levonorgestrel API
10.3 Manufacturing Process Analysis of Levonorgestrel API
10.4 Industry Chain Structure of Levonorgestrel API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Levonorgestrel API Distributors
11.3 Levonorgestrel API Customer
12 World Forecast Review for Levonorgestrel API by Geographic Region
12.1 Global Levonorgestrel API Market Size Forecast by Region
12.1.1 Global Levonorgestrel API Forecast by Region (2023-2030)
12.1.2 Global Levonorgestrel API Annual Revenue Forecast by Region (2023-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Levonorgestrel API Forecast by Type
12.7 Global Levonorgestrel API Forecast by Application
13 Key Players Analysis
13.1 Bayer HealthCare
13.1.1 Bayer HealthCare Company Information
13.1.2 Bayer HealthCare Levonorgestrel API Product Offered
13.1.3 Bayer HealthCare Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer HealthCare Main Business Overview
13.1.5 Bayer HealthCare Latest Developments
13.2 Qinhuangdao Zizhu Pharmaceutical
13.2.1 Qinhuangdao Zizhu Pharmaceutical Company Information
13.2.2 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product Offered
13.2.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Qinhuangdao Zizhu Pharmaceutical Main Business Overview
13.2.5 Qinhuangdao Zizhu Pharmaceutical Latest Developments
13.3 Yangzhou Pharmaceutical
13.3.1 Yangzhou Pharmaceutical Company Information
13.3.2 Yangzhou Pharmaceutical Levonorgestrel API Product Offered
13.3.3 Yangzhou Pharmaceutical Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Yangzhou Pharmaceutical Main Business Overview
13.3.5 Yangzhou Pharmaceutical Latest Developments
13.4 Lupin
13.4.1 Lupin Company Information
13.4.2 Lupin Levonorgestrel API Product Offered
13.4.3 Lupin Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lupin Main Business Overview
13.4.5 Lupin Latest Developments
13.5 Hubei Gedian Humanwell
13.5.1 Hubei Gedian Humanwell Company Information
13.5.2 Hubei Gedian Humanwell Levonorgestrel API Product Offered
13.5.3 Hubei Gedian Humanwell Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hubei Gedian Humanwell Main Business Overview
13.5.5 Hubei Gedian Humanwell Latest Developments
13.6 Sterling Spa
13.6.1 Sterling Spa Company Information
13.6.2 Sterling Spa Levonorgestrel API Product Offered
13.6.3 Sterling Spa Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sterling Spa Main Business Overview
13.6.5 Sterling Spa Latest Developments
13.7 Formos
13.7.1 Formos Company Information
13.7.2 Formos Levonorgestrel API Product Offered
13.7.3 Formos Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Formos Main Business Overview
13.7.5 Formos Latest Developments
13.8 Huazhong Pharm
13.8.1 Huazhong Pharm Company Information
13.8.2 Huazhong Pharm Levonorgestrel API Product Offered
13.8.3 Huazhong Pharm Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Huazhong Pharm Main Business Overview
13.8.5 Huazhong Pharm Latest Developments
13.9 ASG Biochem
13.9.1 ASG Biochem Company Information
13.9.2 ASG Biochem Levonorgestrel API Product Offered
13.9.3 ASG Biochem Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 ASG Biochem Main Business Overview
13.9.5 ASG Biochem Latest Developments
14 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Levonorgestrel API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Levonorgestrel API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Levonorgestrel API by Country/Region, 2019, 2023 & 2030
2.2 Levonorgestrel API Segment by Type
2.2.1 Short-Acting Contraceptive API
2.2.2 Long-Acting Contraceptive API
2.3 Levonorgestrel API Sales by Type
2.3.1 Global Levonorgestrel API Sales Market Share by Type (2019-2022)
2.3.2 Global Levonorgestrel API Revenue and Market Share by Type (2019-2022)
2.3.3 Global Levonorgestrel API Sale Price by Type (2019-2022)
2.4 Levonorgestrel API Segment by Application
2.4.1 Levonorgestrel Tablet
2.4.2 Mixture Products
2.4.3 Hormone-releasing IUD
2.5 Levonorgestrel API Sales by Application
2.5.1 Global Levonorgestrel API Sale Market Share by Application (2019-2022)
2.5.2 Global Levonorgestrel API Revenue and Market Share by Application (2019-2022)
2.5.3 Global Levonorgestrel API Sale Price by Application (2019-2022)
3 Global Levonorgestrel API by Company
3.1 Global Levonorgestrel API Breakdown Data by Company
3.1.1 Global Levonorgestrel API Annual Sales by Company (2020-2022)
3.1.2 Global Levonorgestrel API Sales Market Share by Company (2020-2022)
3.2 Global Levonorgestrel API Annual Revenue by Company (2020-2022)
3.2.1 Global Levonorgestrel API Revenue by Company (2020-2022)
3.2.2 Global Levonorgestrel API Revenue Market Share by Company (2020-2022)
3.3 Global Levonorgestrel API Sale Price by Company
3.4 Key Manufacturers Levonorgestrel API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Levonorgestrel API Product Location Distribution
3.4.2 Players Levonorgestrel API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Levonorgestrel API by Geographic Region
4.1 World Historic Levonorgestrel API Market Size by Geographic Region (2019-2022)
4.1.1 Global Levonorgestrel API Annual Sales by Geographic Region (2019-2022)
4.1.2 Global Levonorgestrel API Annual Revenue by Geographic Region
4.2 World Historic Levonorgestrel API Market Size by Country/Region (2019-2022)
4.2.1 Global Levonorgestrel API Annual Sales by Country/Region (2019-2022)
4.2.2 Global Levonorgestrel API Annual Revenue by Country/Region
4.3 Americas Levonorgestrel API Sales Growth
4.4 APAC Levonorgestrel API Sales Growth
4.5 Europe Levonorgestrel API Sales Growth
4.6 Middle East & Africa Levonorgestrel API Sales Growth
5 Americas
5.1 Americas Levonorgestrel API Sales by Country
5.1.1 Americas Levonorgestrel API Sales by Country (2019-2022)
5.1.2 Americas Levonorgestrel API Revenue by Country (2019-2022)
5.2 Americas Levonorgestrel API Sales by Type
5.3 Americas Levonorgestrel API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Levonorgestrel API Sales by Region
6.1.1 APAC Levonorgestrel API Sales by Region (2019-2022)
6.1.2 APAC Levonorgestrel API Revenue by Region (2019-2022)
6.2 APAC Levonorgestrel API Sales by Type
6.3 APAC Levonorgestrel API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Levonorgestrel API by Country
7.1.1 Europe Levonorgestrel API Sales by Country (2019-2022)
7.1.2 Europe Levonorgestrel API Revenue by Country (2019-2022)
7.2 Europe Levonorgestrel API Sales by Type
7.3 Europe Levonorgestrel API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Levonorgestrel API by Country
8.1.1 Middle East & Africa Levonorgestrel API Sales by Country (2019-2022)
8.1.2 Middle East & Africa Levonorgestrel API Revenue by Country (2019-2022)
8.2 Middle East & Africa Levonorgestrel API Sales by Type
8.3 Middle East & Africa Levonorgestrel API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Levonorgestrel API
10.3 Manufacturing Process Analysis of Levonorgestrel API
10.4 Industry Chain Structure of Levonorgestrel API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Levonorgestrel API Distributors
11.3 Levonorgestrel API Customer
12 World Forecast Review for Levonorgestrel API by Geographic Region
12.1 Global Levonorgestrel API Market Size Forecast by Region
12.1.1 Global Levonorgestrel API Forecast by Region (2023-2030)
12.1.2 Global Levonorgestrel API Annual Revenue Forecast by Region (2023-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Levonorgestrel API Forecast by Type
12.7 Global Levonorgestrel API Forecast by Application
13 Key Players Analysis
13.1 Bayer HealthCare
13.1.1 Bayer HealthCare Company Information
13.1.2 Bayer HealthCare Levonorgestrel API Product Offered
13.1.3 Bayer HealthCare Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer HealthCare Main Business Overview
13.1.5 Bayer HealthCare Latest Developments
13.2 Qinhuangdao Zizhu Pharmaceutical
13.2.1 Qinhuangdao Zizhu Pharmaceutical Company Information
13.2.2 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product Offered
13.2.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Qinhuangdao Zizhu Pharmaceutical Main Business Overview
13.2.5 Qinhuangdao Zizhu Pharmaceutical Latest Developments
13.3 Yangzhou Pharmaceutical
13.3.1 Yangzhou Pharmaceutical Company Information
13.3.2 Yangzhou Pharmaceutical Levonorgestrel API Product Offered
13.3.3 Yangzhou Pharmaceutical Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Yangzhou Pharmaceutical Main Business Overview
13.3.5 Yangzhou Pharmaceutical Latest Developments
13.4 Lupin
13.4.1 Lupin Company Information
13.4.2 Lupin Levonorgestrel API Product Offered
13.4.3 Lupin Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lupin Main Business Overview
13.4.5 Lupin Latest Developments
13.5 Hubei Gedian Humanwell
13.5.1 Hubei Gedian Humanwell Company Information
13.5.2 Hubei Gedian Humanwell Levonorgestrel API Product Offered
13.5.3 Hubei Gedian Humanwell Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hubei Gedian Humanwell Main Business Overview
13.5.5 Hubei Gedian Humanwell Latest Developments
13.6 Sterling Spa
13.6.1 Sterling Spa Company Information
13.6.2 Sterling Spa Levonorgestrel API Product Offered
13.6.3 Sterling Spa Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sterling Spa Main Business Overview
13.6.5 Sterling Spa Latest Developments
13.7 Formos
13.7.1 Formos Company Information
13.7.2 Formos Levonorgestrel API Product Offered
13.7.3 Formos Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Formos Main Business Overview
13.7.5 Formos Latest Developments
13.8 Huazhong Pharm
13.8.1 Huazhong Pharm Company Information
13.8.2 Huazhong Pharm Levonorgestrel API Product Offered
13.8.3 Huazhong Pharm Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Huazhong Pharm Main Business Overview
13.8.5 Huazhong Pharm Latest Developments
13.9 ASG Biochem
13.9.1 ASG Biochem Company Information
13.9.2 ASG Biochem Levonorgestrel API Product Offered
13.9.3 ASG Biochem Levonorgestrel API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 ASG Biochem Main Business Overview
13.9.5 ASG Biochem Latest Developments
14 Research Findings and Conclusion
no record found